Search Results for "Asahi Kasei A Bpep"

05:39 EDT 23rd October 2016 | BioPortfolio

Matching Channels


Matching News

Asahi Kasei licenses Asian rights to Array's ARRY954 in pain, inflammation

Asahi Kasei Corp.'s Asahi Kasei Pharma Corp. division will develop and commercialize Array BioPharma Inc.'s tropomyosin receptor kinase A (TrkA) inhibitors for pain, inflammation, and other indication...

Basilea licenses isavuconazole to Asahi Kasei in Japan

Swiss drugmaker Basilea Pharmaceutica has entered into a partnering agreement with Asahi Kasei Pharma…

BRIEF-Orion Corporation and Asahi Kasei enters into global strategic collaboration

* Says that it has entered into a global strategi collaboration agreement with Japanese Asahi Kasei Pharma for the discovery, development and commercialisation of assets in pain management

Orion and Asahi Kasei reach agreement for pain management assets

Finnish pharmaceutical and diagnostics company Orion has entered a global strategic collaboration agreement with Japan-based Asahi Kasei Pharma to discover, develop and commercialise assets in pain ma...

Basilea licensed Asahi Kasei Pharma rights to isavuconazole in Japan

Basilea Pharmaceutica International Ltd. licensed Asahi Kasei Pharma Corp. exclusive rights to develop and commercialize the antifungal drug isavuconazole in Japan.

Basilea, Asahi Kasei Pharma deal

Basilea Forms Partnership in Japan with Asahi Kasei

Grants exclusive license to develop and commercialize antifungal isavuconazole

Orion Corporation and Asahi Kasei enter into global strategic collaboration

Press Release 22 June 2016 at 8.00 a.m. EEST Orion Corporation and Asahi Kasei enter into global strategic collaboration Orion Corporation, a Finnish pharmaceutical and diagnostics ...

Matching PubMed Articles

Blood Pressure Effects of Yoga, Alone or in Combination With Lifestyle Measures: Results of the Lifestyle Modification and Blood Pressure Study (LIMBS).

The authors conducted a study to assess the effects of yoga on blood pressure (BP). Patients were randomized to yoga (Blood Pressure Education Program [BPEP]), or a combined program (COMBO). Ambulator...

Initial Experience With the Gaia Composite Core Guidewires in Coronary Chronic Total Occlusion Crossing.

Inability to cross the occlusion with a guidewire is the most common cause of failure of coronary chronic total occlusion (CTO) interventions. We describe two cases of successful application of the no...

C-Peptide Level in Fasting Plasma and Pooled Urine Predicts HbA1c after Hospitalization in Patients with Type 2 Diabetes Mellitus.

In this study, we investigate how measures of insulin secretion and other clinical information affect long-term glycemic control in patients with type 2 diabetes mellitus. Between October 2012 and Jun...

Search Whole site using Google

Quick Search
Advertisement Advertisement